Boston Scientific Corp (BSX) 12.44 $BSX
BostonScientific Posts NECTAR-HF Trial Data, Shares Drop - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 03, 2:20PM CDT
The NECTAR-HF trial is the first and only randomized clinical trial examining the efficacy of Boston Scientific's (BSX) investigational vagal nerve stimulation (VNS) device.
Global Heart Valve Repair and Replacement Market 2014-2018 - Key Vendors are Abbott Laboratories, Edward Lifesciences, Medtronic & St. Jude Medical
M2 - Wed Sep 03, 8:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4bq7ck/global_heart) has announced the addition of the "Global Heart Valve Repair and Replacement Market 2014-2018" report to their offering. The Global Heart Valve Repair and Replacement market to grow at a CAGR of 7.72 percent over the period 2013-2018. Heart valves are structures in the human heart which control the flow of blood during the cardiac cycle. A person affected with heart valve diseases such as valvular stenosis, valvular insufficiency or regurgitation, prolapse, and atresia requires the repair or replacement of the natural heart valves. Aortic valves cannot be repaired; therefore, it is replaced using prosthetic heart valves. However, the mitral, tricuspid, and pulmonary valves can be repaired as well as replaced depending on the diseased condition and functionality of these valves. Heart valve repair and replacement devices are used for repairing the diseased heart valves as well as for replacing the natural valves with prosthetic valves. One of the emerging trends in the market is the increase in the number of products approved by regulatory authorities such as the FDA and CE. Such products are considered to be safe for commercial use increasing their adoption rate. According to the report, the increase in the aging population is one of the major drivers in the market. The incidence of cardiac disorders is more prevalent among the aging population across the world and people above the age of 60 years affected by heart valve diseases is expected to contribute to the growth the market. Further, the report states that the potential risk of complications associated with the use of heart valve repair and replacement devices is proving to be a barrier to the adoption of these devices. Some of the complications are device migration, infection, thrombosis, and mortality. In terms of application, the Global Heart Valve Repair and Replacement market can be segmented into two: - Heart Valve Repair - Heart Valve Replacement Key Questions Answered in this Report - What will the market size be in 2018 and what will the growth rate be? - What are the Key Market Trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors? Key Vendors - Abbott Laboratories - Edward Lifesciences - Medtronic - St. Jude Medical Other Prominent Vendors - AorTech - Boston Scientific - Colibri Heart Valve - CryoLife - Direct Flow Medical - JenaValve - MiCardia - Mitralign - Neovasc - On-X Life Technologies - Sorin - Symentis - ValveXchange For more information visit http://www.researchandmarkets.com/research/4b...obal_heart
Boston Scientific To Participate In 2014 Bank Of America Merrill Lynch Global Healthcare Conference
PR Newswire - Wed Sep 03, 7:00AM CDT
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2014 Bank of America Merrill Lynch Global Healthcare Conference on September 17, 2014 in London, England.
Boston Scientific WallFlex Biliary RX Stent Study Succeeds - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 2:20PM CDT
Boston Scientific's (BSX) WallFlex Biliary RX Stent has received CE Mark in Europe for curing biliary strictures produced by malignant neoplasms as well as for benign biliary strictures therapy
3 Top-Ranked Medical Equipment Stocks to Buy Now - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 1:08PM CDT
The fiscal 2015 budget for the Department of Health and Human Services (HHS) has brought a fresh lease on life to the U.S. healthcare economy, following the past years' debacle.
Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG
PR Newswire - Tue Sep 02, 7:00AM CDT
Boston Scientific Corporation (NYSE: BSX) closed on its previously announced agreement to purchase the Interventional business of Bayer AG. The acquisition enhances the ability of Boston Scientific to offer physicians and healthcare systems a more complete portfolio of solutions to treat challenging vascular conditions.
Laparoscopy Devices Market - Global Industry Analysis to 2019
M2 - Mon Sep 01, 3:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mvzpjh/laparoscopy) has announced the addition of the "Laparoscopy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global laparoscopy devices market was valued at USD 7.5 billion in 2012 and is expected to grow at a CAGR of 7.1% from 2013 to 2019, to reach an estimated value of USD 12.3 billion by 2019. The global laparoscopy devices market comprises of equipment such as laparoscope, irrigation system, insufflation devices, trocars, sample retrieval bag, wound protector, internal closure devices, gastric band, hand-assist devices, and energy systems. The segments accounting for large shares in the market include energy systems, trocars, internal closure devices and laparoscope. Although the global market is exhibiting healthy growth rate of 7.1% CAGR over the forecast period, its growth is restrained by certain side effects of laparoscopic procedures, risk of carbon dioxide emissions, and rapidly changing technologies. Introduction of newer technologies will create need for adaptive endoscope accessories. The introduction of innovative techniques such as HD systems in diagnostic instruments, HD cameras and HDTV three chip systems the demand for advanced endoscopy devices have been triggered and this scenario will continue in future. On the basis of applications, the global market for laparoscopy devices is segmented into five major segments, namely, general surgery, bariatric surgery, colorectal surgeries, urological and gynecological surgeries. General surgery accounts for the largest share in the market but the bariatric surgery is the fastest growing application segment immediately followed by colorectal surgery application. The increasing adoption of laparoscopic surgeries for colorectal cancer treatment is due to smaller incisions compared to open colectomy which results into faster recovery and less pain after surgery. Report Scope Laparoscopy Devices Market - Laparoscopes - Irrigation Systems - Insufflation Devices - Trocars - Sample Retrieval Bags - Wound Protectors - Internal Closure Devices - Gastric Bands - Hand-Assist Devices - Energy Systems Company Profiles - Braun Melsungen AG - Boston Scientific Corporation - Cook Medical, Inc. - Covidien PLC - FUJIFILM Holdings Corporation - KARL STORZ GmbH & Co. KG - Olympus Corporation - Richard Wolf GmbH - Smith & Nephew PLC - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/mv...aparoscopy
Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial
PR Newswire Europe - Sat Aug 30, 11:51AM CDT
-- Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure
Boston Scientific Set to Possibly Pullback After Yesterday's Rally of 2.67%
Comtex SmarTrend(R) - Fri Aug 29, 4:05PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $12.39 to a high of $12.74. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $12.55 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Look for Shares of Boston Scientific to Potentially Pullback after Yesterday's 2.67% Rise
Comtex SmarTrend(R) - Fri Aug 29, 4:04PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $12.39 to a high of $12.74. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $12.55 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents
PR Newswire - Fri Aug 29, 4:00PM CDT
A Boston Scientific Corporation (NYSE: BSX) prospective, multinational study on stent removability and preliminary long term stricture resolution of benign biliary strictures has been published in the August issue of the peer-reviewed journal, Gastroenterology.
USIBC Concludes Successful Medical Device Mission to India
Business Wire - Thu Aug 28, 1:50PM CDT
The U.S. India Business Council (USIBC) led a delegation of medical device executives from Abbott, Baxter, Boston Scientific, Covidien, GE Healthcare, Johnson & Johnson, and Medtronic to meet with the new government in New Delhi, India.
Frustrating Boston Scientific Is Not What the Investor Ordered
at The Street - Thu Aug 28, 5:30AM CDT
It will only take one bad quarter for shares to fall to single digits. That's the only time you should buy.
Cardiovascular Monitoring and Diagnostic Devices Market - Global Industry Analysis to 2019
M2 - Thu Aug 28, 5:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sg79m3/cardiovascular) has announced the addition of the "Cardiovascular Monitoring and Diagnostic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Cardiovascular diseases have been the leading cause of death worldwide and will be the leading cause till 2030, according to World Health Organization (WHO). The major factors which increases the burden of this disease are lifestyle habits such as physical inactivity, smoking and unhealthy diet. These factors which result in obesity and hypertension are also identified as the underlying cause of cardiovascular disorders. The number of people diagnosed with coronary artery disease, peripheral artery disease, pulmonary embolism and congenital heart disease is rising rapidly worldwide. Therefore, the need for preventive healthcare has arisen and realized by countries with high burden of these disorders. Thus, the demand for cardiovascular monitoring and diagnostic devices is expected to rise in such countries. Based on the product type, the global cardiovascular monitoring and diagnostic devices market is categorized into six segments namely ECG systems, cardiovascular diagnostic catheters, holter monitors, event monitors, implantable loop recorders and ECG management systems. Among these, ECG systems held the majority share of the global cardiovascular monitoring and diagnostic devices market in 2012, while the global market for implantable loop recorders is expected to grow at a faster pace during the forecast period. The ECG systems market is majorly dominated by the resting ECG systems owing to higher demand from customers due to convenience in the procedure. The demand for these systems will rise further owing to their lower price and rising demand from patients. Also, it is more convenient to be used among elderly patients and patients at high risk of congestive heart failure. Geographically, the global cardiovascular monitoring and diagnostic devices market is categorized into four regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). North America dominated the global cardiovascular monitoring and diagnostic devices market in 2012 due to high patient awareness coupled with the presence of sophisticated healthcare infrastructure. Also, the adoption of new technologies is rapid in this region which results in high demand for advanced cardiovascular monitoring and diagnostic devices. Conversely, the Asia-Pacific region is expected to grow at a higher CAGR, owing to the high presence of unmet healthcare needs, high patient population and increasing healthcare expenditure. Cardiovascular Monitoring and Diagnostic Devices Market, by Product Type - ECG Systems - Stress ECG - Resting ECG - Cardiovascular Diagnostic Catheters - Event Monitors - Holter Monitors - Implantable Loop Recorders - ECG Management Systems Company Profiles - Boston Scientific Corporation - Covidien plc - FUKUDA DENSHI Co., Ltd. - GE Healthcare - Johnson & Johnson - Medtronic, Inc. - Nihon Kohden Corporation - Philips Healthcare - Siemens Healthcare - Sorin Group - Spacelabs Healthcare - St. Jude Medical, Inc. - Welch Allyn For more information visit http://www.researchandmarkets.com/research/sg...iovascular
Endoscopy Global Market - Forecast to 2020: Key Vendors are Johnson and Johnson, Olympus Corporation & Covidien plc
M2 - Thu Aug 28, 4:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m48n4s/endoscopy_global) has announced the addition of the "Endoscopy Global Market - Forecast to 2020" report to their offering. The global endoscopy market is expected to reach approximately $43 billion by 2019 growing at around 7.0% CAGR from 2014 to 2019. The major drivers for the market growth are aging population, increase in cancer, diabetes, and obesity patients along with a rise in patient's preference for minimal invasive surgeries. Additionally, shorter stay in hospitals, speedy recovery, and reduced medical budget are expected to enhance the endoscopy market growth. However, the shortage of qualified endoscopic technicians, high cost of initial investment, contamination risk and patient safety of endoscopic procedures pose a threat for the market growth. Advancement in the field of endoscopic devices with accurate visibility, high definition imaging and documentation, ease of handling and cleaning the devices and growing demand in emerging countries brings in more opportunities for the endoscopy market. North America accounts for the largest market share with increase in endoscopic treatment options and obese population followed by Europe and Japan. Although U.S. has a high market share, there is a growing demand for endoscopy market in the emerging countries such as India and China. Along with an increase in medical spending, improvement in medical infrastructure and changes in life style attribute to the growth of the market in emerging countries. Some of the leading players accounting for major market share include Johnson and Johnson (U.S.), Olympus Corporation (Japan) and Covidien plc (U.K.). The other significant players are Boston Scientific Corporation (U.S.), Stryker Corporation (U.S.), Smith & Nephew (U.K.) and Karl Storz (Germany). Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Analysis 4. Endoscopy Market, by Application 5. Endoscopy Market, by Products 6. Regional Market Analysis 7. Company Developments 8. Major Company Profiles - Artherx, Inc - Boston Scientific Corporation - Covidien plc - Fujiflim Holdings Corporation - Hoya Corporation - Johnson and Johnson (Ethicon) - Karl Storz - Olympus Corporation - Smith & Nephew - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/m4...opy_global
Dayton's Newest and Most Exciting Community Now Available for Sale
PRWeb - Tue Aug 26, 8:09AM CDT
Lennar, the number one ranked homebuilder for the eighth consecutive year in the Twin Cities, is unveiling Dayton's newest community now available for sale. Sundance Woods is located in the prestigious Maple Grove school district and is bordered by the Sundance Woods Golf Course. The community also offers a heavily wooded perimeter throughout. Sundance Woods is conveniently located near the Shoppes at Arbor Lakes and many major area employers, including the Target North Campus, Boston Scientific campus and the Maple Grove Hospital. Sundance Woods also provides easy access to major highways nearby; this tucked away oasis is perfect for city commuters.
European Medical Electrodes (Diagnostics Electrodes & Therapeutic Electrodes) Market Report 2014-2018 with 3M, Ambu, ConMed, Covidien & GE Healthcare Dominating
M2 - Tue Aug 26, 6:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bs4bg7/medical) has announced the addition of the "Medical Electrodes Market in Europe 2014-2018" report to their offering. The Medical Electrodes market in Europe to grow at a CAGR of 8.32 percent over the period 2013-2018. Electrodes are electrical conductors used in the manufacture of medical devices to detect chemical reactions through electrical impulses. The detection of electrical signals aid in the diagnosis of various diseases and disorders. Medical electrodes are regularly employed in various medical devices such as defibrillators, ECG, EEG, EMG, ENG, electrosurgical devices, fetal scalp monitors, nasopharyngeal devices, neurological devices, pacemakers, and TENS. Disposable electrodes are designed to offer convenient one-time application. Also, disposable electrodes have lower electrical resistance and greater capacitance than reusable electrodes. Therefore, disposable medical electrodes are comparatively more hygienic and efficient. Hence, the market is witnessing a shift toward an increase in the use of disposable electrodes to avoid hospital-acquired infections. Also, disposable electrodes are cost-effective and flexible for use in patients According to the report the growth of the Medical Electrodes market in Europe is driven by several factors. Reimbursement policy is one of the major factors driving the growth of the market in Europe. The growing aging population is another driver contributing toward an increase in the use of medical devices. This in turn is boosting the adoption of medical electrodes. Further, the report states the growth of the Medical Electrodes market in Europe is curtailed by certain serious challenges. One of the main challenges in this market is the biocompatibility of electrodes. To meet international standards for medical electrodes, biocompatibility is a must. Key Vendors - 3M - Ambu - ConMed - Covidien - GE Healthcare Other Prominent Vendors - Boston Scientific - Cooper Surgical - Dymedix - Thermo Fisher - Vermed - ZOLL Medical For more information visit http://www.researchandmarkets.com/research/bs4bg7/medical
Why St. Jude Medical Has Become a Must-Own Medical Device Stock
at The Street - Tue Aug 26, 5:00AM CDT
Wall Street isn't ready to credit management for some of the company's restructuring and value-building efforts, many of which should fuel long-term growth.
North American Interventional Cardiology & Peripheral Vascular Devices (Angioplasty Balloon, Stent, Catheter, IVC Filter, Endovascular Stent Graft) Market Report
M2 - Tue Aug 26, 3:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pxpdkk/north_american) has announced the addition of the "North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon, Stent, Catheter, IVC Filter, Endovascular Stent Graft - Forecast to 2018" report to their offering. The North American interventional cardiology and peripheral vascular devices market is expected to grow at a CAGR of 2.9% from 2013 to 2018. Both, the lower volume of coronary angioplasty procedures and the increasing prevalence rate of peripheral artery diseases have impacted the market significantly. Amongst all the product segments, bioabsorbable stents, retrievable inferior vena cava filters, and diagnostic catheters (intravascular ultrasound and optical coherence tomography catheters) markets are identified as the high growth segments in the North American interventional cardiology and peripheral vascular devices market. Better diagnosis of thrombus using IVUS and OCT catheters is expected to drive the diagnostic catheters market; whereas, lesser risk of long-term post surgical complications in DVT/PE treatments will encourage faster adoption of the retrievable inferior vena cava filters in the coming years. The bioabsorbable stents are still not available for clinical usage in the U.S. However, bioabsorbable stents are available on a special access basis by Health Canada. The usage factors of different surgical instruments were the major hindrances while deriving the market size of the corresponding surgical devices. This is primarily due to the availability of various surgical instruments for the treatment of similar cardiac ailments. For instance, coronary angioplasty can be performed through plain balloon catheter, stent, and/or a combination of stent and catheter, based on patients' cardiac health. The study on the North American interventional cardiology and peripheral vascular devices market captures an exhaustive list of surgical devices which are used in various types of angioplasty procedures, deep vein thrombosis, endovascular aneurysm repairing, and chronic total occlusion (CTO) treatment procedures. This research illustrates specific driving and restraining factors in the U.S. and Canadian markets; furthermore, it identifies the high-growth regions with regard to the interventional cardiology and peripheral vascular devices market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Angioplasty Balloons 6 Angioplasty Stents 7 Catheters Market 8 Endovascular Aneurysm Repair (EVAR) Stent Grafts Market 9 Inferior Vena Cava (IVC) Filters Market 10 Plaque Modification Devices Market 11 Hemodynamic Flow Alteration Devices Market 12 Accessory Devices Market 13 Geographic Analysis 14 Competitive Landscape 15 Company Profiles - Abbott Laboratories - Biotronik SE & Co. Kg - Boston Scientific Corporation - B. Braun Melsungen AG - Cook Medical, Inc. - Cordis Corporation - Covidien Plc - C. R. Bard, Inc. - Medtronic Inc. - W.L.Gore & Associates, Inc. For more information visit http://www.researchandmarkets.com/research/px...h_american
BostonScientific Posts NECTAR-HF Trial Data, Shares Drop - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 03, 2:20PM CDT
The NECTAR-HF trial is the first and only randomized clinical trial examining the efficacy of Boston Scientific's (BSX) investigational vagal nerve stimulation (VNS) device.
Global Heart Valve Repair and Replacement Market 2014-2018 - Key Vendors are Abbott Laboratories, Edward Lifesciences, Medtronic & St. Jude Medical
M2 - Wed Sep 03, 8:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4bq7ck/global_heart) has announced the addition of the "Global Heart Valve Repair and Replacement Market 2014-2018" report to their offering. The Global Heart Valve Repair and Replacement market to grow at a CAGR of 7.72 percent over the period 2013-2018. Heart valves are structures in the human heart which control the flow of blood during the cardiac cycle. A person affected with heart valve diseases such as valvular stenosis, valvular insufficiency or regurgitation, prolapse, and atresia requires the repair or replacement of the natural heart valves. Aortic valves cannot be repaired; therefore, it is replaced using prosthetic heart valves. However, the mitral, tricuspid, and pulmonary valves can be repaired as well as replaced depending on the diseased condition and functionality of these valves. Heart valve repair and replacement devices are used for repairing the diseased heart valves as well as for replacing the natural valves with prosthetic valves. One of the emerging trends in the market is the increase in the number of products approved by regulatory authorities such as the FDA and CE. Such products are considered to be safe for commercial use increasing their adoption rate. According to the report, the increase in the aging population is one of the major drivers in the market. The incidence of cardiac disorders is more prevalent among the aging population across the world and people above the age of 60 years affected by heart valve diseases is expected to contribute to the growth the market. Further, the report states that the potential risk of complications associated with the use of heart valve repair and replacement devices is proving to be a barrier to the adoption of these devices. Some of the complications are device migration, infection, thrombosis, and mortality. In terms of application, the Global Heart Valve Repair and Replacement market can be segmented into two: - Heart Valve Repair - Heart Valve Replacement Key Questions Answered in this Report - What will the market size be in 2018 and what will the growth rate be? - What are the Key Market Trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors? Key Vendors - Abbott Laboratories - Edward Lifesciences - Medtronic - St. Jude Medical Other Prominent Vendors - AorTech - Boston Scientific - Colibri Heart Valve - CryoLife - Direct Flow Medical - JenaValve - MiCardia - Mitralign - Neovasc - On-X Life Technologies - Sorin - Symentis - ValveXchange For more information visit http://www.researchandmarkets.com/research/4b...obal_heart
Boston Scientific To Participate In 2014 Bank Of America Merrill Lynch Global Healthcare Conference
PR Newswire - Wed Sep 03, 7:00AM CDT
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2014 Bank of America Merrill Lynch Global Healthcare Conference on September 17, 2014 in London, England.
Boston Scientific WallFlex Biliary RX Stent Study Succeeds - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 2:20PM CDT
Boston Scientific's (BSX) WallFlex Biliary RX Stent has received CE Mark in Europe for curing biliary strictures produced by malignant neoplasms as well as for benign biliary strictures therapy
3 Top-Ranked Medical Equipment Stocks to Buy Now - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 1:08PM CDT
The fiscal 2015 budget for the Department of Health and Human Services (HHS) has brought a fresh lease on life to the U.S. healthcare economy, following the past years' debacle.
Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG
PR Newswire - Tue Sep 02, 7:00AM CDT
Boston Scientific Corporation (NYSE: BSX) closed on its previously announced agreement to purchase the Interventional business of Bayer AG. The acquisition enhances the ability of Boston Scientific to offer physicians and healthcare systems a more complete portfolio of solutions to treat challenging vascular conditions.
Laparoscopy Devices Market - Global Industry Analysis to 2019
M2 - Mon Sep 01, 3:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mvzpjh/laparoscopy) has announced the addition of the "Laparoscopy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global laparoscopy devices market was valued at USD 7.5 billion in 2012 and is expected to grow at a CAGR of 7.1% from 2013 to 2019, to reach an estimated value of USD 12.3 billion by 2019. The global laparoscopy devices market comprises of equipment such as laparoscope, irrigation system, insufflation devices, trocars, sample retrieval bag, wound protector, internal closure devices, gastric band, hand-assist devices, and energy systems. The segments accounting for large shares in the market include energy systems, trocars, internal closure devices and laparoscope. Although the global market is exhibiting healthy growth rate of 7.1% CAGR over the forecast period, its growth is restrained by certain side effects of laparoscopic procedures, risk of carbon dioxide emissions, and rapidly changing technologies. Introduction of newer technologies will create need for adaptive endoscope accessories. The introduction of innovative techniques such as HD systems in diagnostic instruments, HD cameras and HDTV three chip systems the demand for advanced endoscopy devices have been triggered and this scenario will continue in future. On the basis of applications, the global market for laparoscopy devices is segmented into five major segments, namely, general surgery, bariatric surgery, colorectal surgeries, urological and gynecological surgeries. General surgery accounts for the largest share in the market but the bariatric surgery is the fastest growing application segment immediately followed by colorectal surgery application. The increasing adoption of laparoscopic surgeries for colorectal cancer treatment is due to smaller incisions compared to open colectomy which results into faster recovery and less pain after surgery. Report Scope Laparoscopy Devices Market - Laparoscopes - Irrigation Systems - Insufflation Devices - Trocars - Sample Retrieval Bags - Wound Protectors - Internal Closure Devices - Gastric Bands - Hand-Assist Devices - Energy Systems Company Profiles - Braun Melsungen AG - Boston Scientific Corporation - Cook Medical, Inc. - Covidien PLC - FUJIFILM Holdings Corporation - KARL STORZ GmbH & Co. KG - Olympus Corporation - Richard Wolf GmbH - Smith & Nephew PLC - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/mv...aparoscopy
Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial
PR Newswire Europe - Sat Aug 30, 11:51AM CDT
-- Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure
Boston Scientific Set to Possibly Pullback After Yesterday's Rally of 2.67%
Comtex SmarTrend(R) - Fri Aug 29, 4:05PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $12.39 to a high of $12.74. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $12.55 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Look for Shares of Boston Scientific to Potentially Pullback after Yesterday's 2.67% Rise
Comtex SmarTrend(R) - Fri Aug 29, 4:04PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $12.39 to a high of $12.74. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $12.55 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents
PR Newswire - Fri Aug 29, 4:00PM CDT
A Boston Scientific Corporation (NYSE: BSX) prospective, multinational study on stent removability and preliminary long term stricture resolution of benign biliary strictures has been published in the August issue of the peer-reviewed journal, Gastroenterology.
USIBC Concludes Successful Medical Device Mission to India
Business Wire - Thu Aug 28, 1:50PM CDT
The U.S. India Business Council (USIBC) led a delegation of medical device executives from Abbott, Baxter, Boston Scientific, Covidien, GE Healthcare, Johnson & Johnson, and Medtronic to meet with the new government in New Delhi, India.
Frustrating Boston Scientific Is Not What the Investor Ordered
at The Street - Thu Aug 28, 5:30AM CDT
It will only take one bad quarter for shares to fall to single digits. That's the only time you should buy.
Cardiovascular Monitoring and Diagnostic Devices Market - Global Industry Analysis to 2019
M2 - Thu Aug 28, 5:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sg79m3/cardiovascular) has announced the addition of the "Cardiovascular Monitoring and Diagnostic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Cardiovascular diseases have been the leading cause of death worldwide and will be the leading cause till 2030, according to World Health Organization (WHO). The major factors which increases the burden of this disease are lifestyle habits such as physical inactivity, smoking and unhealthy diet. These factors which result in obesity and hypertension are also identified as the underlying cause of cardiovascular disorders. The number of people diagnosed with coronary artery disease, peripheral artery disease, pulmonary embolism and congenital heart disease is rising rapidly worldwide. Therefore, the need for preventive healthcare has arisen and realized by countries with high burden of these disorders. Thus, the demand for cardiovascular monitoring and diagnostic devices is expected to rise in such countries. Based on the product type, the global cardiovascular monitoring and diagnostic devices market is categorized into six segments namely ECG systems, cardiovascular diagnostic catheters, holter monitors, event monitors, implantable loop recorders and ECG management systems. Among these, ECG systems held the majority share of the global cardiovascular monitoring and diagnostic devices market in 2012, while the global market for implantable loop recorders is expected to grow at a faster pace during the forecast period. The ECG systems market is majorly dominated by the resting ECG systems owing to higher demand from customers due to convenience in the procedure. The demand for these systems will rise further owing to their lower price and rising demand from patients. Also, it is more convenient to be used among elderly patients and patients at high risk of congestive heart failure. Geographically, the global cardiovascular monitoring and diagnostic devices market is categorized into four regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). North America dominated the global cardiovascular monitoring and diagnostic devices market in 2012 due to high patient awareness coupled with the presence of sophisticated healthcare infrastructure. Also, the adoption of new technologies is rapid in this region which results in high demand for advanced cardiovascular monitoring and diagnostic devices. Conversely, the Asia-Pacific region is expected to grow at a higher CAGR, owing to the high presence of unmet healthcare needs, high patient population and increasing healthcare expenditure. Cardiovascular Monitoring and Diagnostic Devices Market, by Product Type - ECG Systems - Stress ECG - Resting ECG - Cardiovascular Diagnostic Catheters - Event Monitors - Holter Monitors - Implantable Loop Recorders - ECG Management Systems Company Profiles - Boston Scientific Corporation - Covidien plc - FUKUDA DENSHI Co., Ltd. - GE Healthcare - Johnson & Johnson - Medtronic, Inc. - Nihon Kohden Corporation - Philips Healthcare - Siemens Healthcare - Sorin Group - Spacelabs Healthcare - St. Jude Medical, Inc. - Welch Allyn For more information visit http://www.researchandmarkets.com/research/sg...iovascular
Endoscopy Global Market - Forecast to 2020: Key Vendors are Johnson and Johnson, Olympus Corporation & Covidien plc
M2 - Thu Aug 28, 4:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m48n4s/endoscopy_global) has announced the addition of the "Endoscopy Global Market - Forecast to 2020" report to their offering. The global endoscopy market is expected to reach approximately $43 billion by 2019 growing at around 7.0% CAGR from 2014 to 2019. The major drivers for the market growth are aging population, increase in cancer, diabetes, and obesity patients along with a rise in patient's preference for minimal invasive surgeries. Additionally, shorter stay in hospitals, speedy recovery, and reduced medical budget are expected to enhance the endoscopy market growth. However, the shortage of qualified endoscopic technicians, high cost of initial investment, contamination risk and patient safety of endoscopic procedures pose a threat for the market growth. Advancement in the field of endoscopic devices with accurate visibility, high definition imaging and documentation, ease of handling and cleaning the devices and growing demand in emerging countries brings in more opportunities for the endoscopy market. North America accounts for the largest market share with increase in endoscopic treatment options and obese population followed by Europe and Japan. Although U.S. has a high market share, there is a growing demand for endoscopy market in the emerging countries such as India and China. Along with an increase in medical spending, improvement in medical infrastructure and changes in life style attribute to the growth of the market in emerging countries. Some of the leading players accounting for major market share include Johnson and Johnson (U.S.), Olympus Corporation (Japan) and Covidien plc (U.K.). The other significant players are Boston Scientific Corporation (U.S.), Stryker Corporation (U.S.), Smith & Nephew (U.K.) and Karl Storz (Germany). Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Analysis 4. Endoscopy Market, by Application 5. Endoscopy Market, by Products 6. Regional Market Analysis 7. Company Developments 8. Major Company Profiles - Artherx, Inc - Boston Scientific Corporation - Covidien plc - Fujiflim Holdings Corporation - Hoya Corporation - Johnson and Johnson (Ethicon) - Karl Storz - Olympus Corporation - Smith & Nephew - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/m4...opy_global
Dayton's Newest and Most Exciting Community Now Available for Sale
PRWeb - Tue Aug 26, 8:09AM CDT
Lennar, the number one ranked homebuilder for the eighth consecutive year in the Twin Cities, is unveiling Dayton's newest community now available for sale. Sundance Woods is located in the prestigious Maple Grove school district and is bordered by the Sundance Woods Golf Course. The community also offers a heavily wooded perimeter throughout. Sundance Woods is conveniently located near the Shoppes at Arbor Lakes and many major area employers, including the Target North Campus, Boston Scientific campus and the Maple Grove Hospital. Sundance Woods also provides easy access to major highways nearby; this tucked away oasis is perfect for city commuters.
European Medical Electrodes (Diagnostics Electrodes & Therapeutic Electrodes) Market Report 2014-2018 with 3M, Ambu, ConMed, Covidien & GE Healthcare Dominating
M2 - Tue Aug 26, 6:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bs4bg7/medical) has announced the addition of the "Medical Electrodes Market in Europe 2014-2018" report to their offering. The Medical Electrodes market in Europe to grow at a CAGR of 8.32 percent over the period 2013-2018. Electrodes are electrical conductors used in the manufacture of medical devices to detect chemical reactions through electrical impulses. The detection of electrical signals aid in the diagnosis of various diseases and disorders. Medical electrodes are regularly employed in various medical devices such as defibrillators, ECG, EEG, EMG, ENG, electrosurgical devices, fetal scalp monitors, nasopharyngeal devices, neurological devices, pacemakers, and TENS. Disposable electrodes are designed to offer convenient one-time application. Also, disposable electrodes have lower electrical resistance and greater capacitance than reusable electrodes. Therefore, disposable medical electrodes are comparatively more hygienic and efficient. Hence, the market is witnessing a shift toward an increase in the use of disposable electrodes to avoid hospital-acquired infections. Also, disposable electrodes are cost-effective and flexible for use in patients According to the report the growth of the Medical Electrodes market in Europe is driven by several factors. Reimbursement policy is one of the major factors driving the growth of the market in Europe. The growing aging population is another driver contributing toward an increase in the use of medical devices. This in turn is boosting the adoption of medical electrodes. Further, the report states the growth of the Medical Electrodes market in Europe is curtailed by certain serious challenges. One of the main challenges in this market is the biocompatibility of electrodes. To meet international standards for medical electrodes, biocompatibility is a must. Key Vendors - 3M - Ambu - ConMed - Covidien - GE Healthcare Other Prominent Vendors - Boston Scientific - Cooper Surgical - Dymedix - Thermo Fisher - Vermed - ZOLL Medical For more information visit http://www.researchandmarkets.com/research/bs4bg7/medical
Why St. Jude Medical Has Become a Must-Own Medical Device Stock
at The Street - Tue Aug 26, 5:00AM CDT
Wall Street isn't ready to credit management for some of the company's restructuring and value-building efforts, many of which should fuel long-term growth.
North American Interventional Cardiology & Peripheral Vascular Devices (Angioplasty Balloon, Stent, Catheter, IVC Filter, Endovascular Stent Graft) Market Report
M2 - Tue Aug 26, 3:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pxpdkk/north_american) has announced the addition of the "North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon, Stent, Catheter, IVC Filter, Endovascular Stent Graft - Forecast to 2018" report to their offering. The North American interventional cardiology and peripheral vascular devices market is expected to grow at a CAGR of 2.9% from 2013 to 2018. Both, the lower volume of coronary angioplasty procedures and the increasing prevalence rate of peripheral artery diseases have impacted the market significantly. Amongst all the product segments, bioabsorbable stents, retrievable inferior vena cava filters, and diagnostic catheters (intravascular ultrasound and optical coherence tomography catheters) markets are identified as the high growth segments in the North American interventional cardiology and peripheral vascular devices market. Better diagnosis of thrombus using IVUS and OCT catheters is expected to drive the diagnostic catheters market; whereas, lesser risk of long-term post surgical complications in DVT/PE treatments will encourage faster adoption of the retrievable inferior vena cava filters in the coming years. The bioabsorbable stents are still not available for clinical usage in the U.S. However, bioabsorbable stents are available on a special access basis by Health Canada. The usage factors of different surgical instruments were the major hindrances while deriving the market size of the corresponding surgical devices. This is primarily due to the availability of various surgical instruments for the treatment of similar cardiac ailments. For instance, coronary angioplasty can be performed through plain balloon catheter, stent, and/or a combination of stent and catheter, based on patients' cardiac health. The study on the North American interventional cardiology and peripheral vascular devices market captures an exhaustive list of surgical devices which are used in various types of angioplasty procedures, deep vein thrombosis, endovascular aneurysm repairing, and chronic total occlusion (CTO) treatment procedures. This research illustrates specific driving and restraining factors in the U.S. and Canadian markets; furthermore, it identifies the high-growth regions with regard to the interventional cardiology and peripheral vascular devices market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Angioplasty Balloons 6 Angioplasty Stents 7 Catheters Market 8 Endovascular Aneurysm Repair (EVAR) Stent Grafts Market 9 Inferior Vena Cava (IVC) Filters Market 10 Plaque Modification Devices Market 11 Hemodynamic Flow Alteration Devices Market 12 Accessory Devices Market 13 Geographic Analysis 14 Competitive Landscape 15 Company Profiles - Abbott Laboratories - Biotronik SE & Co. Kg - Boston Scientific Corporation - B. Braun Melsungen AG - Cook Medical, Inc. - Cordis Corporation - Covidien Plc - C. R. Bard, Inc. - Medtronic Inc. - W.L.Gore & Associates, Inc. For more information visit http://www.researchandmarkets.com/research/px...h_american
